(EMAILWIRE.COM, September 21, 2018 ) The global epigenetics market is projected to reach USD 1,605.7 Million by 2022 from USD 854.0 Million in 2017, at a CAGR of 13.5% during the forecast period. Market growth can be attributed to the decreasing sequencing costs, increase in research activities, availability of funding for epigenetics research, and rising prevalence of cancer.

Know More: https://www.marketsandmarkets.com/Market-Reports/epigenetics-technologies-market-896.html

In this report, the global epigenetics market has been segmented on the basis of product, application, technology, end user, and region. Based on product, the global market for epigenetics, is segmented into enzymes, instruments and consumables, kits, reagents, and bioinformatics tools. In 2016, the kits segment accounted for the largest share of global market for epigenetics. The large share of this segment is attributed to the fact that a large number of kits are used in epigenetic techniques. The rising prevalence of a number of diseases, increasing R&D spending, and increased government funding for life science research are the other factors supporting market growth.

Based on application, the global epigenetics market is segmented into oncology, development biology, metabolic diseases, developmental biology, immunology, cardiovascular diseases, and other applications (includes neurology, gynecology, and infectious diseases). The metabolic diseases segment is expected to register the highest CAGR during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=896

On the basis of technology, the epigenetics market is segmented into DNA methylation, histone modification, and other technologies (includes non-coding RNA and chromatin remodeling). In 2016, the DNA methylation segment dominated the global market for epigenetics, in 2016. The ability of this technique to study different types of cancer with quality outcomes is the key factor supporting market growth.

On the basis of end users, the epigenetics market is segmented into academic and research institutes, pharmaceutical and biotechnology companies, and contract research organizations (CROs). In 2016, the academic and research institutes segment dominated the global market for epigenetics. The large share of this segment is attributed to the increasing prevalence of various diseases and growth in research-based activities which leads to the higher adoption of epigenetic products like enzymes, instruments & consumables, kits, and reagents.